ReviewFrontiers in psychiatry2025
Less is more: calorie restriction as a therapeutic for mental health disorders.
Review in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anxiety, depression, and substance use disorders are prevalent mental health disorders that have debilitating health outcomes, and current treatment options are not always efficacious or tolerable. Calorie restriction (CR) has various health benefits, with research efforts focused on its effects in improving metabolic health and delaying biological aging. Recent studies have indicated that CR can also improve anxiety-, depression- and addiction-like symptoms and behavior. Similar benefits have also been observed in studies investigating a range of CR mimetics (CRMs) - molecules that mimic one or more of the physiological effects of CR without dietary restriction - indicating that both CR and CRMs could be used to assist in treating these symptoms. Here, we summarize the current evidence for the potential use of CR and select CRMs in the treatment of anxiety, depression, and addiction, as well as the possible molecular mechanisms underlying these beneficial effects. Finally, we propose novel molecular signatures that could be exploited to screen for novel CRM candidates.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.